Literature DB >> 24481815

STAT3 and MCL-1 associate to cause a mesenchymal epithelial transition.

A P Renjini1, Shiny Titus, Prashanth Narayan, Megha Murali, Rajesh Kumar Jha, Malini Laloraya.   

Abstract

Embryo implantation is effected by a myriad of signaling cascades acting on the embryo-endometrium axis. Here we show, by using MALDI TOF analysis, far-western analysis and colocalization and co-transfection studies, that STAT3 and MCL-1 are interacting partners during embryo implantation. We show in vitro that the interaction between the two endogenous proteins is strongly regulated by estrogen and progesterone. Implantation, pregnancy and embryogenesis are distinct from any other process in the body, with extensive, but controlled, proliferation, cell migration, apoptosis, cell invasion and differentiation. Cellular plasticity is vital during the early stages of development for morphogenesis and organ homeostasis, effecting the epithelial to mesenchymal transition (EMT) and, the reverse process, mesenchymal to epithelial transition (MET). STAT3 functionally associates with MCL-1 in the mammalian breast cancer cell line MCF7 that overexpresses STAT3 and MCL-1, which leads to an increased rate of apoptosis and decreased cellular invasion, disrupting the EMT. Association of MCL-1 with STAT3 modulates the normal, anti-apoptotic, activity of MCL-1, resulting in pro-apoptotic effects. Studying the impact of the association of STAT3 with MCL-1 on MET could lead to an enhanced understanding of pregnancy and infertility, and also metastatic tumors.

Entities:  

Keywords:  Apoptosis; Epithelial mesenchymal transition; Invasion; MET; STAT3–MCL-1 interaction

Mesh:

Substances:

Year:  2014        PMID: 24481815     DOI: 10.1242/jcs.138214

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  7 in total

1.  TNF overproduction impairs epithelial staphylococcal response in hyper IgE syndrome.

Authors:  Ian A Myles; Erik D Anderson; Noah J Earland; Kol A Zarember; Inka Sastalla; Kelli W Williams; Portia Gough; Ian N Moore; Sundar Ganesan; Cedar J Fowler; Arian Laurence; Mary Garofalo; Douglas B Kuhns; Mark D Kieh; Arhum Saleem; Pamela A Welch; Dirk A Darnell; John I Gallin; Alexandra F Freeman; Steven M Holland; Sandip K Datta
Journal:  J Clin Invest       Date:  2018-07-23       Impact factor: 14.808

2.  Arm Selection Preference of MicroRNA-193a Varies in Breast Cancer.

Authors:  Kuo-Wang Tsai; Chung-Man Leung; Yi-Hao Lo; Ting-Wen Chen; Wen-Ching Chan; Shou-Yu Yu; Ya-Ting Tu; Hing-Chung Lam; Sung-Chou Li; Luo-Ping Ger; Wen-Shan Liu; Hong-Tai Chang
Journal:  Sci Rep       Date:  2016-06-16       Impact factor: 4.379

3.  miR-193b and miR-30c-1* inhibit, whereas miR-576-5p enhances melanoma cell invasion in vitro.

Authors:  Theresa Kordaß; Claudia E M Weber; David Eisel; Antonino A Pane; Wolfram Osen; Stefan B Eichmüller
Journal:  Oncotarget       Date:  2018-08-21

4.  ID09, A Newly-Designed Tubulin Inhibitor, Regulating the Proliferation, Migration, EMT Process and Apoptosis of Oral Squamous Cell Carcinoma.

Authors:  Qiushi Feng; Panpan Yang; He Wang; Congshan Li; Tomoka Hasegawa; Zhaopeng Liu; Minqi Li
Journal:  Int J Biol Sci       Date:  2022-01-01       Impact factor: 6.580

Review 5.  Epithelial-to-Mesenchymal Transition in the Female Reproductive Tract: From Normal Functioning to Disease Pathology.

Authors:  Olena Bilyk; Mackenzie Coatham; Michael Jewer; Lynne-Marie Postovit
Journal:  Front Oncol       Date:  2017-07-05       Impact factor: 6.244

Review 6.  Myeloid cell leukemia 1 (MCL-1), an unexpected modulator of protein kinase signaling during invasion.

Authors:  Adelaide Ij Young; Paul Timpson; David Gallego-Ortega; Christopher J Ormandy; Samantha R Oakes
Journal:  Cell Adh Migr       Date:  2017-12-21       Impact factor: 3.405

7.  Assembling custom side chains on proteoglycans to interrogate their function in living cells.

Authors:  Wenshuang Wang; Naihan Han; Yingying Xu; Yunxue Zhao; Liran Shi; Jorge Filmus; Fuchuan Li
Journal:  Nat Commun       Date:  2020-11-20       Impact factor: 14.919

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.